In addition to inducing glycolytic metabolism, it has been shown that p53 can also act as a downstream target gene of CPT2 and play a role in promoting proliferation, migration, and invasion, as well as apoptosis, by affecting its activity in colorectal cancer cells [130]. Here, CPT2 is linked to colorectal cancer.